the development of immunotherapies in the treatment of relapsed metastatic head and neck cancer
Published 6 years ago • 135 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:59
potential of immunotherapy in head and neck cancer
-
3:14
factors predicting the outcome of immunotherapy to patients with head and neck cancer
-
1:09
the future role of immunotherapy in head and neck cancers
-
0:39
predicting responses to immunotherapy in head and neck cancer
-
2:12
unanswered questions in head and neck cancer
-
3:12
novel immunotherapy approaches in metastatic head and neck cancer
-
1:59
pembrolizumab in the treatment of head and neck cancer: is there more to the story?
-
47:43
understanding immune activation and evasion in the tumor microenvironment: why lymphocyte...
-
2:06
the resurgence of immunotherapy in the treatment of cancer
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
0:58
checkpoint inhibitors for head and neck cancer in the definitive setting?
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
1:52
esmo 2022 highlights in head and neck cancer
-
4:06
immunotherapy for head and neck cancer treatment
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
1:32
dr. cohen on immunotherapy combinations in head and neck cancer
-
2:54
extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer
-
18:05
head & neck cancer update - webinar
-
1:56
dr. weiss on the role of immunotherapy in head and neck cancer